Synthesis and Antimicrobial Evaluation of Some Novel Derivatives of Coumarin Moiety

 

Abhishek Kumar*, Prerana Shetty, Amrutha C. L, Derin Reona Vaz, Ashlin Baby

Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences, NITTE University, Paneer, Deralakatte-575018, Mangalore, Karnataka.

*Corresponding Author E-mail: abhi12bunty@gmail.com

 

 

 

 

Received on 09.03.2016          Modified on 15.03.2016

Accepted on 02.04.2016        © RJPT All right reserved

Research J. Pharm. and Tech. 2016; 9(5): 545-548.

DOI: 10.5958/0974-360X.2016.00103.7

 

 

ABSTRACT:

A series of novel substituted 3-(2-hydroxy-6-phenylpyrimidin-4-yl)-2-H-chromen-2-one and 3-(2-mercapto-6-phenylpyrimidin-4-yl)-2-H-chromen-2-one (APY1-APY8) were synthesized upon refluxing ethanolic solution of  3-(3-phenylacryloyl)-2-H-chromen-2-one with urea/thiourea in presence of 20% KOH. The structures of the final synthesized compounds were characterized by IR, mass and 1H NMR spectra. The synthesized compounds were screened for their antibacterial activity against Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa by cup plate method. Most of the compounds exhibited promising antibacterial activity.                                                                                                                                                                       

 

KEYWORDS: Chalcones, pyrimidines, 3-acetyl coumarin, antibacterial activity.

 

 


INTRODUCTION:

Coumarins are group of secondary plant metabolites found to exhibit important pharmacological activities. Some of their 3-substituted derivatives such as novobiocin, coumaromycin and chartencin are known to exhibit antibacterial activity. Coumarin derivatives have been reported to possess anticoagulant, antibacterial1, anti-inflammatory2, antioxidant3, anthelmintic and anticancer4 activities. Nitrogen containing heterocycles such as pyrimidine is a promising structural moiety for drug designing. Pyrimidine derivatives are known to be biologically active compounds and substituted pyrimidines have shown wide range of biological activities like antitubercular5, antibacterial6, antioxidant7 and anti-inflammatory8 activity.                                                                                                                           

 

The incorporation of two moieties increases biological activity of both and thus it was of value to synthesize some new heterocyclic derivatives having two moiety in the same molecule. By considering the above facts it was contemplated to synthesize a new series of pyrimidine derivatives incorporating the coumarin moiety and evaluate their antimicrobial activities.       

 

MATERIALS AND METHODS:

All the chemicals were of analytical grade: substituted salicylaldehyde, ethylacetoacetate, absolute ethanol, piperidine, urea, thiourea and substituted benzaldehyde. Melting points were determined by open capillary method and are uncorrected. The purity of the compounds was monitored by thin layer chromatography (TLC) using silica gel G plates. The spots were visualized under UV light and by the exposure to iodine vapors. The homogeneity of the compounds were checked on silica gel-G coated plate by using Ethylacetate: Chloroform (9:1) as solvent. IR spectra were recorded in Alpha Bruker using ATR method. 1H NMR spectra were recorded on Bruker spectrophotometer (400 MHz) in DMSO-d6 solvent using tetra methyl silane (TMS) as an internal standard. Mass spectra was recorded by LCMS method.

General Procedure:

Synthesis of Substituted 3-(3-phenylacryloyl)-2-H-chromen-2-one9

A mixture of substituted 3-acetyl-coumarin (0.01 mol) and different substituted benzaldehyde (0.01 mol) in 20 ml absolute ethanol was stirred together at room temperature for 24 hours in the presence of 20% KOH. The completion of the reaction was monitored by TLC. The reaction mixture was then poured into crushed ice and acidified with 2N HCl with stirring. The product obtained was filtered, washed with water and recrystallised from ethanol.

 

 

Synthesis of Substituted 3-(2-hydroxy-6-phenylpyrimidin-4-yl)-2-H-chromen-2-one and 3-(2-mercapto-6-phenylpyrimidin-4-yl)-2-H-chromen-2-one10 (APY1- APY8)

A mixture of substituted 3-(3-phenylacryloyl)-2-H-chromen-2-one (0.01 mol) and urea/thiourea (0.01 mol) was dissolved in 20 ml absolute ethanol in the presence of 20% KOH. The reaction mixture was refluxed for about 6 hours. After the completion of the reaction, the reaction mixture was poured into crushed ice. The precipitated solid was filtered, washed with cold water and recrystallised from ethanol.

 

 


 

Figure 1: Reaction scheme for Pyrimidine derivatives


Spectral data

3-(2-hydroxy-6-(3,4,5-trimethoxyphenyl)pyrimidin-4-yl)-2H-chromen-one (APY1)

IR KBr (cm-1): 1512 (Ar C=C str), 835 (Ar C-H bend), 3056 (Ar C-H str), 1692 (C=N str), 1268 (C-O str), 1698 (C=O str), 3482 (O-H str).

1H NMR (400 MHz, DMSO-d6): δ 7.31-8.12 (m, 10H, Ar-H), 9.82 (s, 1H, OH), 3.26 (s, 3H, OCH3).

MS (M+): m/z 421.

 

3-(2-mercapto-6-(3,4,5-trimethoxyphenyl)pyrimidin-4-yl)-2H-chromen-one (APY2)

IR KBr (cm-1): 1516 (Ar C=C str), 832 (Ar C-H bend), 3050 (Ar C-H str), 1690 (C=N str), 1272 (C-O str), 1692 (C=O str), 2052 (S-H str).

1H NMR (400 MHz, DMSO-d6): δ 7.27-8.16 (m, 10H, Ar-H), 9.85 (s, 1H, OH), 3.36 (s, 3H, OCH3).  

MS (M+): m/z 437.

 

6-chloro-3-(2-hydroxy-6-(4-nitrophenyl)- pyrimidin-4-yl)-2H-chromen-one (APY5)

IR KBr (cm-1): 1508 (Ar C=C str), 830 (Ar C-H bend), 3054 (Ar C-H str), 1688 (C=N str), 1696 (C=O str), 1342 (Ar-NO2 str), 732 (C-Cl str), 3476 (O-H str).

1H NMR (400 MHz, DMSO-d6): δ 7.12-8.16 (m, 10H, Ar-H), 12.19 (s, 1H, SH)  

MS (M+): m/z 395.

 

 

 

6-chloro-3-(2-mercapto-6-(4-nitrophenyl)- pyrimidin-4-yl)-2H-chromen-one (APY6)

IR KBr (cm-1): 1518 (Ar C=C str), 836 (Ar C-H bend), 3058 (Ar C-H str), 1680(C=N str), 1696 (C=O str), 1340 (Ar-NO2 str), 736 (C-Cl str), 2048 (S-H str).

1H NMR (400 MHz, DMSO-d6): δ 7.15-8.19 (m, 10H, Ar-H), 12.13 (s, 1H, SH)

MS (M+): m/z 411.

 

Antimicrobial Activity:

All the synthesized compounds were evaluated for their antibacterial activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Bacillus subtilis using cup plate method11. The synthesized test compounds were tested at a concentration of  100 µg/50µl and the standard compound i.e. Ciprofloxacin were tested at 25 µg/50µl. Dimethyl formamide (DMF) was used as control. In this technique, melted agar inoculated with microorganisms is poured into petridishes. Wells are made in the agar plate and a specific volume of the antimicrobial substances are placed in them, plates were incubated at a temperature of 37oC for 24 hrs. The antimicrobial substance diffuses through agar around its well and produces a clear zone of inhibition. The diameter of this zone (mm) gives an estimation of the degree of activity of the antimicrobial substance.

 

 


RESULTS AND DISCUSSION:

 

Table 1: Physicochemical data of 2-Hydroxy Pyrimidines

Comp. code

R

R1

Mol. formula

Mol. wt

M.P oC

Rf Value

% Yield

APY1

H

3,4,5-OCH3

C23H21N2O6

421

198-200

0.70

78

APY3

H

3-NO2

C19H11N3O5

361

210-212

0.68

69

APY5

5-Cl

4-NO2

C19H10ClN3O5

395

226-228

0.64

58

APY7

3,5-Br

3-NO2

C19H9Br2N3O5

519

240-242

0.72

59

 

 

Table 2: Physicochemical data of 2-Mercapto Pyrimidines

Comp. code

R

R1

Mol. formula

Mol. wt

M.P oC

Rf Value

% Yield

APY2

H

3,4,5-OCH3

C23H21N2O5S

437

206-208

0.76

75

APY4

H

3-NO2

C19H11N3O4S

377

216-218

0.60

76

APY6

5-Cl

4-NO2

C19H10ClN3O4S

411

230-232

0.66

60

APY8

3,5-Br

3-NO2

C19H9Br2N3O4S

535

234-238

0.62

62

 

 

Table 3: Antimicrobial activity of the compounds (RPY1-RPY8) by cup plate method

Compd

Diameter of zone of inhibition (mm)

S.aureus

B.subtilis

E.coli

P.aureginosa

APY1

15

18

13

12

APY2

19

16

14

13

APY3

10

12

11

09

APY4

08

10

09

08

APY5

18

19

17

16

APY6

17

16

13

15

Ciprofloxacin

26

26

22

23

Control

-

-

-

-

 


Antimicrobial activity

The in vitro antibacterial and antifungal activity of the synthesized compounds were determined by using cup-plate method. The results of antibacterial and antifungal activity of newly synthesized compounds are reported  against Bacillus subtilis, Staphylococcus aureus, Escherichia  coli and Pseudomonas  aeruginosa. Compounds APY1, APY2, APY5 and APY6 showed good antibacterial activity compared to the standard drug ciprofloxacin. The results of the antimicrobial activity are summarized in Table 3.

 

CONCLUSION:

This study reports the successful synthesis of substituted pyrimidine derivatives with moderate yields and most of the synthesized compounds showed promising antibacterial activity.

 

ACKNOWLEDGEMENTS:

The authors are thankful to Nitte University for providing the necessary facilities to carry out this research. The authors are grateful to Sequent Research Ltd, Mangalore and Central Instrumentation Facility, MIT Manipal for providing spectroscopic data

 

REFERENCES:

1.     Mulvad VV, Pawar BR. Synthesis and some antibacterial compounds from 4-hydroxycoumarin. Ind J Chem. 2003; 42B: 2091.

2.     Kontogiorgis CA, Hadjipavlou LD. Synthesis and antiinflammatory activity of coumarin derivatives. J Med Chem. 2005; 48: 6400-6408.

3.     Nicolaides DN et al. Synthesis and biological evaluation of several coumarin-4-carboxamide and 3-(coumarin-4-yl)-1, 2, 4-oxadiazole derivatives. J Med Chem. 1998; 33: 715-724.

4.     Lapez GJS et al. Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer. 2004; 43: 275-283.

5.     Mohan SB et. al. Microwave-assisted synthesis, molecular docking and antitubercular activity of 1,2,3,4-tethydro-pyrimidin-5-carbonitrile derivatives. Bioorg Med Chem Lett. 2010; 22(24): 7539-7542.

6.     Hilmy KM et al. Synthesis of new pyrrole [2,3-d] pyrimidine derivatives as antibacterial and antifungal agents. Eur J Med Chem. 2010; 45(11): 5243-5250.

7.     Kumar SM et al. In-vitro antioxidant studies of 4,6-bis aryl-pyrimidin-2-amine derivatives. IJRPBS. 2011; 2(4): 1568-1570.

8.     El-Gazzar A-RBA et al. Synthesis and biological evaluation of thieno [2,3-d] pyrimidine derivatives for anti-inflammatory, analgesic and ulcerogenic activity. Acta Pharm. 2007; 57(4): 395-411.

9.     Jayashree BS et al. Synthesis of some coumarinyl chalcones of pharmacological interest. Asian Journal of Chemistry. 2009; 21(8): 5918-5922.

10.   Trivedi AR et al. Synthesis and biological evaluation of some new pyrimidines via a novel chalcones series. Arkivoc. 2008; (xi): 131-141.

11.   Ojala T et al. Antimicrobial  activity of some coumarin containing herbal plants growing in Finland. J Ethnopharmacol. 2000; 73(1-2): 299-305.